China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

Market Cap	19.02B
Revenue (ttm)	10.32B
Net Income (ttm)	1.35B
Shares Out	1.03B
EPS (ttm)	1.31
PE Ratio	14.12
Forward PE	10.83
Dividend	0.20 (1.08%)
Ex-Dividend Date	Nov 8, 2024

Volume	12,392,100
Average Volume	13,052,726
Open	18.73
Previous Close	18.80
Day's Range	18.52 - 18.97
52-Week Range	17.19 - 26.15
Beta	0.17
RSI	38.79
Earnings Date	Mar 20, 2025

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, and other. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing Pharmaceutical Group Co., Ltd.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 12,269
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2023, SHA:600062's revenue was 10.22 billion, an increase of 6.20% compared to the previous year's 9.63 billion. Earnings were 1.33 billion, an increase of 12.96%.